Home/ Supplements/ Probiotics/ Infant Probiotic

Infant Probiotic

product on market Powder Smidge Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

The probiotic blend contains beneficial bacteria designed to support infant gut health and digestive function. Research provides moderate evidence that these strains may help reduce the duration of colic and improve stool consistency. The safety profile for these ingredients is high in infant populations.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Infant Probiotic
Open Full PDF View on NIH DSLD →
Details

Label Data

20 mg
Serving Size
750
Servings
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 80.0mg (20 products) 337 studies (A:8, B:183)
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: Use one Smidge spoonful (20 mg). Take once a day, with food, or as directed by a practitioner.

Warnings & Precautions

Do not use if the safety seal is broken or missing.

Keep out of reach of children.

Formulation Notes

Free of the following common allergens: Milk/casein, eggs, fish, shellfish, tree nuts, peanuts, wheat, gluten, sesame, and soybeans. No artificial colors, flavors, or preservatives.

Small batch supplements

Gentle formula

Gluten and dairy free No added prebiotics

Additional Information

Storage: Keep refrigerated with lid on.

Metadata

Product Details

UPC / SKU8 50019 90203 7
DSLD Entry Date2025-09-25
Product TypeNon-Nutrient/Non-Botanical
FormPowder
BrandSmidge
DSLD ID337912
Data Updated2026-04-11
Research

Research Evidence

691
Research Sources
52
Avg Quality
255
Clinical Trial
205
Meta Analysis
123
Rct
81
Systematic Review
18
Cochrane Review
2
Guideline
2
Regulatory Source
1
Other
1
Narrative Review
1
Openfda Safety
A Probiotics for preventing acute upper respiratory tract infections
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Probiotics for preventing acute upper respiratory tract infections
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Probiotics for maintenance of remission in ulcerative colitis
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Probiotics for induction of remission in ulcerative colitis
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Probiotics for preventing acute upper respiratory tract infections
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Probiotics for treating eczema
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Probiotics for treating acute infectious diarrhoea
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A The Gut Microbiome in Depression and Potential Benefit of Prebiotics, Probiotics and Synbiotics: A Systematic Review of Clinical Trials and Observational Studies
Systematic Review International journal of molecular sciences 2022 PubMed DOI
A Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Probiotics to prevent infantile colic
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
View all evidence for Probiotics →
Compare

Similar Products

View all Probiotics products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.